CSIMarket Company Name, Ticker, Industry, else..


Cardiff Lexington Corporation  (CDIF)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


 

Cardiff Lexington Corporation

CDIF's Financial Statements and Analysis



Cardiff Lexington Corporation reported in the forth quarter of 2024 net loss per share of $0.00 compare to earnings per share of $0.00 in the same quarter a year ago and improved compare to net loss per share of $-0.16 realized in previous quarter.


forth quarter of 2024
Earnings Per Share Revenues
$ 0 $  3 Mill
Unch.     $+1M     +50.65 %



Cardiff Lexington's Revenue rose by 50.65 % in forth quarter of 2024 (Dec 31 2024) year on year, to $3 million and advanced by 130.2 % sequentially.


Cardiff Lexington is

More on CDIF's Income Statement



Cardiff Lexington in the forth quarter of 2024 recorded net loss of $-0.910 million, compare to net income of $0.247 million achieved in IV. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-1.978 million realized in previous quarter.

More on CDIF's Growth

Cardiff Lexington Inventories
Inventories declined by 0 % to $0.54 million from IV. Quarter a year ago, sequentially inventories fell by 0 %. In Dec 31 2024 company's net cash and cash equivalents decreased by $-1 million


Cardiff Lexington Corporation does not pay out common stock dividend.

In trailing twelve-month period Cardiff Lexington Corporation payed $ -0.51 cash per share, on a free-cash flow basis .

Book value fell by -12.08 % sequentially to $0.23 per share, -10.32% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ -0.70 per share from $ -0.35.

Company repurchased 2.55 million shares or 18.10 % in Dec 31 2024.


• More on CDIF's Dividends

 Market Capitalization (Millions) 0
 Shares Outstanding (Millions) 12
 Total Debt (Millions $) 1
 Revenue (TTM) (Millions $) 8
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Cardiff Lexington Corporation does not pay out common stock dividend.

In trailing twelve-month period Cardiff Lexington Corporation had negative $ -0.51 cash flow per share, on a free-cash flow basis .

Book value fell by -12.08 % sequentially to $0.23 per share, -10.32% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ -0.70 per share from $ -0.35.

Company repurchased 2.55 million shares or 18.10 % in Dec 31 2024.


• More on CDIF's Balance Sheets

 Market Capitalization (Millions) 0
 Shares Outstanding (Millions) 12
 Total Debt (Millions $) 1
 Revenue (TTM) (Millions $) 8
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Cardiff Lexington Corporation Earnings

Cardiff Lexington Corporation Faces Revenue Setback: -6.95% Decline in Latest Fiscal Period

Cardiff Lexington Corporation, a company in the Healthcare Facilities industry, has experienced a decline in financial performance during the January to March 31, 2024 time-frame. This is in stark contrast to the overall industry, which has seen a rise in revenue.
The company's deficit per share for this time-frame increased to $-0.13, compared to $0.00 the previous year and $0.00 in the previous reporting period. This indicates a significant decline in profitability.
Additionally, the revenue for Cardiff Lexington Corporation decreased by -6.95% to $2.66 million from $2.86 million in the comparable financial reporting period a year ago. However, there was an improvement in revenue on a sequential ...

Cardiff Lexington Corporation Demonstrates Resilience Despite Tough Financial Period

Cardiff Lexington Corporation, despite facing a tough financial interval closing on December 31, 2023, has managed to achieve significant improvements and display resilience in the face of adversity. While CDIF's gain per share remained at $0.00, it is important to note that this is a significant leap from the previous year's loss of $-0.01 per share.
Furthermore, CDIF's revenue experienced a considerable decline of -19.263% to $2.07 million from $2.57 million in the same reporting period a year ago. However, it is important to highlight that this dip was also seen across the entire Healthcare Facilities sector, making CDIF's performance in line with industry trends. Additionally, there was a sequential ...

Cardiff Lexington Corp Generates Impressive $3.44M Revenue, Enhancing Future Prospects



In the recently released financial report, Cardiff Lexington Corporation (CDIF) showcased a commendable performance, reaching a break-even point despite facing moderate revenue growth. The company's revenue rose by 2.302% to $3.44 million in the period ending September 30, 2023, compared to the same reporting season a year before. While CDIF's revenue increase trailed behind peers in the Healthcare Facilities sector, it demonstrated an 8.73% relative revenue rise compared to the same period last year. This article aims to analyze these financial results and speculate on their potential impact on the company's future.
Steady Revenue Growth:
With a revenue growth rate of 2.302%, Cardiff Lexin...

Breaking News: Cardiff Lexington Corporation Achieves 11.245% Revenue Boost, Crushing Expectations in Q2 2023!

Cardiff Lexington Corporation, a healthcare facilities company, has reported strong financial results for the second quarter of 2023. The company achieved a per share value of $0.00, which is the same as the previous year, but an improvement from the previous reporting season. In terms of revenue, Cardiff Lexington saw a significant increase of 11.245% to $3.48 million compared to $3.13 million in the same period last year. Sequentially, the company's revenue improved by 21.743% from $2.86 million.
One notable achievement for Cardiff Lexington is its outperformance in the healthcare facilities sector. While the sector's peers reported a 7.53% increase in revenue in the same period, Cardiff Lexington surp...

Cardiff Lexington Corporation's Earnings Remain Steady at $0.00 Amid Slight Revenue Dip to $2.86M in Q1 2023

Cardiff Lexington Corporation, a leader in the stock market, has recently released its financial earnings for the period ending March 31, 2023, and the results are nothing short of impressive. Despite a modest decline in revenue of -2.727% to $2.86 million year on year, the company managed to deliver unscathed earnings per share with an EPS of $0.00, showcasing its resilience and ability to weather challenges successfully.
Comparing the figures to the preceding reporting period, Cardiff Lexington Corporation has made significant strides. In the previous period, earnings per share were reported at $-0.01, while revenue had increased by an impressive 11.498% to $2.57 million. This positive growth demonstra...


Date modified: 2025-03-16T19:20:48+00:00





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com